Literature DB >> 8499892

Characterization of the serum requirement for macrophage-mediated killing of Treponema pallidum ssp. pallidum: relationship to the development of opsonizing antibodies.

S A Baker-Zander1, J M Shaffer, S A Lukehart.   

Abstract

Serum pools were collected from rabbits bled at various times after intra-testicular infection with Treponema pallidum ssp. pallidum. These were tested for their ability to opsonize T. pallidum and promote killing of the organisms by macrophages. Compared to normal sera, significant opsonization was first seen on day 10 of infection as measured by both ingestion (P < 0.001) and macrophage-mediated killing (P = 0.006); significant levels of functional antibodies persisted through 300 days of infection. Although opsonic activity peaked early in infection, antibodies that promoted optimal macrophage-mediated killing developed much later, suggesting that these two functions may represent activities of antibodies with differing specificities or affinities. The initial development of antibodies that augment both phagocytosis and killing corresponds with the in vivo clearance of treponemes from the primary site of infection. These observations support the hypothesis that macrophages are the major effector mechanism for elimination of T. pallidum during early syphilis infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499892     DOI: 10.1111/j.1574-695X.1993.tb00339.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  16 in total

1.  Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog.

Authors:  D V Shevchenko; T J Sellati; D L Cox; O V Shevchenko; E J Robinson; J D Radolf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.

Authors:  Christina M Marra; Lauren C Tantalo; Sharon K Sahi; Shelia B Dunaway; Sheila A Lukehart
Journal:  J Infect Dis       Date:  2015-12-09       Impact factor: 5.226

Review 5.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

6.  Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.

Authors:  Nikhat Parveen; Mark C Fernandez; Austin M Haynes; Rui-Li Zhang; B Charmie Godornes; Arturo Centurion-Lara; Lorenzo Giacani
Journal:  Vaccine       Date:  2019-02-20       Impact factor: 3.641

7.  Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis.

Authors:  Rebecca E LaFond; Barbara J Molini; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

8.  Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Identification of the Treponema pallidum subsp. pallidum TP0092 (RpoE) regulon and its implications for pathogen persistence in the host and syphilis pathogenesis.

Authors:  Lorenzo Giacani; Oleg Denisenko; Martin Tompa; Arturo Centurion-Lara
Journal:  J Bacteriol       Date:  2012-12-14       Impact factor: 3.490

Review 10.  Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens.

Authors:  Kirk W Deitsch; Sheila A Lukehart; James R Stringer
Journal:  Nat Rev Microbiol       Date:  2009-06-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.